IRVINE, Calif., May 16, 2024 /PRNewswire/ -- GATC Health Corp, a technology company advancing drug discovery and disease prediction using artificial intelligence (AI), has successfully completed two external AI platform validation tests in collaboration with a pharmaceutical science lab at University of California, Irvine's (UCI). UCI specifically designed the tests to independently verify the performance of GATC Health's AI's primary drug screening capabilities and provide unique and detailed insights into drug success risks. The successful outcome of the tests mark a significant milestone in the advancement of AI in drug discovery.
Nutcracker Therapeutics’ Research Partner, the University of California, San Francisco, Presents Foundational Prostate Cancer Data at AAI 2024
The team screened a library of more than 1,000 compounds and discovered that an old, experimental cancer drug called kenpaullone enhances the expression of the gene KCC2, which is essential for silencing pain signals. The drug was effective in treating mouse models of pain from nerve injury and bone cancer, they reported in the journal Nature Communications.
University of California, Irvine’s Health Affairs and Syntropy recently announced a new, five-year strategic partnership to transform how data is integrated and contextualized across the health research and health care continuum. The partnership supports the work to connect clinical-, research- and patient-reported data across the entire UCI enterprise while setting a new precedent for data utilization in scientific discovery.
Describing a previously unknown genetic condition that affects children, researchers at University of California San Diego School of Medicine and Rady Children's Institute for Genomic Medicine say they also found a potential method to prevent the gene mutation by administering a drug during pregnancy.
Delix Therapeutics, named a 2021 Fierce 15 winner today, has secured $70 million to bring two psychedelic analogs through phase 1 trials to treat brain disorders and boost its drug discovery work.
The City of Hope team, in conjunction with Menzies Health Institute Queensland at Griffith University, packaged a protein-based anti-HIV drug into “nanosized” cell fragments called exosomes. When the researchers treated mouse models of HIV with the drug, it tamped down HIV levels in the brain as well as in the bone marrow and spleen, they reported in Nature Communications.
Smartphones are already being used to read COVID-19 test results, screen for conditions ranging from autism to pancreatic cancer and manage ultrasound wands, cardiac monitors and other medical devices. Soon enough, the iPhone in your pocket could also automatically detect mental health issues like depression, anxiety and cognitive decline—all based on the daily activity data already gathered by the device.